Table 3.
Gene | Ratio | All Patients N = 22 |
cCRFs N = 19 |
Diabetes mellitus | Dyslipidemia | Hypertension | |||
---|---|---|---|---|---|---|---|---|---|
OB-nDM N = 17 |
OB-DM N = 5 |
OB-nDLP N = 11 |
OB-DLP N = 11 |
OB-nHT N = 15 |
OB-HT N = 7 |
||||
AGER | 0.85 | 0.072 | 0.184 | 0.193 | 0.138 | 0.051 | 0.534 | 0.140 | 0.176 |
ANGPT1 | 1.56 | 0.001 | 0.005 | 0.002 | 0.500 | 0.016 | 0.026 | 0.003 | 0.311 |
ANGPT2 | 1.73 | 0.011 | 0.009 | 0.013 | 0.500 | 0.374 | 0.013 | 0.027 | 0.176 |
CAPG | 1.17 | 0.049 | 0.045 | 0.108 | 0.225 | 0.049 | 0.373 | 0.270 | 0.066 |
CD34 | 1.09 | 0.406 | 0.414 | 0.069 | 0.225 | 0.819 | 0.371 | 0.900 | 0.264 |
CD68 | 1.23 | 0.013 | 0.013 | 0.028 | 0.225 | 0.182 | 0.033 | 0.054 | 0.091 |
COL18A1 | 1.10 | 0.170 | 0.089 | 0.286 | 0.343 | 0.277 | 0.024 | 0.775 | 0.086 |
DLL4 | 1.30 | 0.053 | 0.070 | 0.042 | 0.893 | 0.497 | 0.029 | 0.016 | 0.828 |
ENG | 1.20 | 0.055 | 0.081 | 0.087 | 0.345 | 0.289 | 0.110 | 0.105 | 0.243 |
IFI30 | 1.17 | 0.083 | 0.020 | 0.269 | 0.080 | 0.746 | 0.052 | 0.566 | 0.033 |
NOTCH3 | 3.98 | <0.001 | <0.001 | <0.001 | 0.043 | 0.003 | 0.003 | <0.001 | 0.018 |
PECAM1 | 1.52 | 0.002 | 0.006 | 0.006 | 0.225 | 0.062 | 0.016 | 0.004 | 0.176 |
PGF | 0.83 | 0.072 | 0.091 | 0.084 | 0.686 | 0.051 | 0.594 | 0.100 | 0.866 |
PLIN2 | 1.15 | 0.143 | 0.382 | 0.280 | 0.686 | 0.073 | 0.825 | 0.226 | 0.428 |
PNPLA2 | 1.31 | 0.004 | 0.011 | 0.013 | 0.138 | 0.041 | 0.021 | 0.202 | 0.018 |
PTX3 | 1.11 | 0.046 | 0.108 | 0.050 | 0.500 | 0.013 | 0.657 | 0.088 | 0.237 |
SERPINF1 | 1.50 | <0.001 | <0.0001 | <0.001 | 0.080 | <0.001 | 0.004 | 0.002 | 0.018 |
SPP1 | 2.90 | <0.001 | 0.003 | 0.003 | 0.225 | 0.021 | 0.016 | 0.001 | 0.237 |
TEK | 1.24 | 0.029 | 0.031 | 0.050 | 0.500 | 0.213 | 0.086 | 0.128 | 0.145 |
TNC | 3.03 | <0.001 | <0.001 | <0.001 | 0.080 | 0.003 | 0.008 | 0.004 | 0.018 |
VEGFA | 0.86 | 0.076 | 0.096 | 0.376 | 0.080 | 0.024 | 0.395 | 0.005 | 0.957 |
Red: upregulated in subcutaneous p < 0.005; green: downregulated in subcutaneous p < 0.05.